INTRODUCTION
Mirizzi syndrome, a complication of long-standing gallstone disease, has reported prevalence rate of 0.05-2.1% in developed Western countries, and 4.7-5.7% in other regions of the world. It occurs in approximately 0.1% of patients suffering from gallstones and found in 0.7-2.5% of cholecystectomies. 1, 2 Proposed pathophysiology is explained by impaction of stones in the cystic duct or neck of the gallbladder (Hartmann's pouch). Persistent impaction and chronic inflammatory response will cause external obstruction of the common bile duct (CBD), necrosis, fibrosis, and ultimately fuse into the CBD to form cholecystocholedochal fistula. [3] [4] [5] Predisposing factors for development of Mirizzi syndrome were suggested to be a long cystic duct that is parallel to the bile duct and the low insertion of the cystic duct into the CBD. 4 Recurrent or continuous impaction of gallstones may lead to repeated attacks of acute cholecystitis and will cause the gallbladder to become initially distended with thick inflamed walls, and consequently will become contracted and atrophic, characterized by thicker fibrotic walls. When the gallbladder becomes atrophic, its wall may become atrophic thick or thin; and in some cases, these walls could intimately adhere to the contained gallstones. 5 Proximity of acutely or chronically inflamed gallbladder to the CBD could lead walls to fuse by the edematous inflammatory tissue. In time, it will become fibrotic contributing to external compression of the CBD and resulting in characteristic obstructive jaundice seen with this condition. This late process could be acute or chronic. 6 Clinically, Mirizzi syndrome is presented as recurrent episodes of obstructive jaundice (60%-100%), right upper quadrant (RUQ) abdominal pain (50%-100%), recurrent cholangitis, and fever in a patient with known or suspected gallstone disease. 7 Laboratory investigations may reveal leukocytosis, hyperbilirubinemia, high alkaline phosphatase, and elevated aminotransaminase levels, often observed with acute cholecystitis, pancreatitis, or cholangitis. 8 Preoperative diagnosis of Mirizzi syndrome is often difficult and can be detected in approximately 8-62.5% of patients. 9 Therefore, we evaluate and analyze effectiveness of diagnostic modalities and treatment options in our series of Mirizzi Syndrome in 64 Saudi Arabian patients. According to Cendes classification, we classified patients based on intraoperative findings to 49 (76.6%) pa- Patients completed three years follow-up postoperatively, and no late complications were recorded.
MATERIALS AND METHODS
Morbidity rate was (3.1%) and the mortality rate was 0% (Fig. 3, Table 3 ).
DISCUSSION
Patient's age group in our series is 29-53 that is much lower than reported range worldwide and could be explained by the fact that most of our gallbladder disease patients are in the same age range. Conversely, female to male ratio agrees with results reported in the literature. 10 In our study, 49 (76.6%) patients had Cendes type I disease. The majority of studies published in the literature have reported type I disease as the most frequent type (10.5% to 51%), and Mirizzi IV as uncommon (1% to 4%). Mirizzi V could manifest in up to 29% patients with other subtypes of Mirizzi. 8 Only 2 (3.1%) patients in our series had Cendes type IV, consistent with the literature.
In 1989, Csendes et al. 11 classified Mirizzi syndrome into five (I to V) groups, to aid surgical treatment of patients.
Beltran proposed a more simplified classification for Mirizzi syndrome 12 (Tables 4 and 5 ).
Radiological diagnosis is initially by abdominal ultrasound that has diagnostic accuracy of 29%, with reported sensitivity varying from 8.3%-27%. 9 CT has a sensitivity of 42%. 13 Only 17 (26.6%) of our patients presented with clinically detected jaundice had a diagnostic CT scan.
Magnetic resonance cholangiopancreatography (MRCP)
has a diagnostic accuracy of 50%. 14 Unfortunately, MRCP
was not available in our facility during the study period to be evaluated as preoperative diagnostic modality. 16 In our approach, a thorough initial diagnostic laparoscopy was the standard option to explicitly identify anatomy as well as pathology associated with CBD taking several screenshots for documentation, followed by careful and meticulous dissection and exploration of the cystic duct and artery with minimal traction conducted and a second diagnostic broad panoramic view before clipping Extrinsic compression of the common bile duct by an impacted gallstone Cholecystobiliary fistula secondary to an eroded gallstone involving one-third of the circumference of the common bile duct Cholecystobiliary fistula involving two-thirds of the circumference of the common bile duct Cholecystobiliary fistula comprising the whole circumference of the common bile duct Any type plus a cholecystoenteric fistula Management of Mirizzi syndrome is always surgical and is challenging for the operating surgeon because the condition is difficult to diagnose preoperatively and in 50% of cases is diagnosed during surgery. Distorted anatomy and dense adhesions due to severe inflammation are associated with significantly increased risk of CBD injury and bleeding. 17 Intraoperative diagnosis is suggested by presence of dense fibrous adhesions between the gallbladder and CBD, and a contracted gallbladder. 15 In our study, 53.1% of cases that identified intraoperatively had the same features. Dense adhesions were reported in all cases.
It has been suggested that in patients with suspected
Mirizzi syndrome, fundus first approach is recommended. 16 Fundus of the gallbladder is opened, the stone is extracted and cystic duct stone is retrieved from the gallbladder, a reasonable approach we conducted in four cases, but it needs much attention not to cause perforation or avulsion of the cystic duct, and more importantly, to avoid CBD injury. As disease progresses, the anatomy will eventually be- Postoperative complications and mortality rates in our study were minimal despite that complexity of the diseases had progressed in approximately one-third of patients while other earlier studies revealed that as the disease progresses, mortality and morbidity rates increase. 7, [20] [21] [22] [23] [24] Due to the careful approach we used in all patients, and that is the most significant message of this study, Mirizzi syndrome cases should not be underestimated.
Recent published reports associated gallbladder cancer with subtypes of Mirizzi syndrome with an incidence of 5.3%-28% of patients. It was discovered exclusively in patients with subtype II or higher, and patients diagnosed with Mirizzi syndrome with biliary-enteric fistulas (Mirizzi subtype Va). 25 In our series, histopathology examination of the gallbladder postoperatively was negative for malignant changes in all patients.
Comparing the three groups in our study, group 3 (patients diagnosed initially by ultrasound) had the best treatment outcome, the least morbidity, and the shortest hospital stay. It indicates the significance of preoperative diagnosis and thus, a careful treatment approach.
Accordingly, we developed a treatment algorithm and clinical pathway for management of Mirizzi syndrome in our hospital that significantly improved our safe approach to address challenges of Mirizzi syndrome cases (Fig. 4) .
Given our results and based on our protocol, we would like to emphasize stress significant messages of this study. In conclusion, suspected cases of Mirizzi syndrome should not be underestimated. Difficulty in establishing preoperative diagnosis is a major dilemma. As it is mostly encountered intraoperatively, the approach should be careful and logical to identify the correct type of Mirizzi by a thorough diagnostic laparoscopy and thus, provide optimum treatment for the particular subtype to achieve the best management outcome.
